Applications of nanomaterials in tissue engineering

X Zheng, P Zhang, Z Fu, S Meng, L Dai, H Yang - RSC advances, 2021 - pubs.rsc.org
Recent advancement in nanotechnology has brought prominent benefits in tissue
engineering, which has been used to repair or reconstruct damaged tissues or organs and …

PLGA particles in immunotherapy

D Horvath, M Basler - Pharmaceutics, 2023 - mdpi.com
Poly (lactic-co-glycolic acid)(PLGA) particles are a widely used and extensively studied drug
delivery system. The favorable properties of PLGA such as good bioavailability, controlled …

Nanovaccine: A novel approach in immunization

SM Gheibi Hayat, M Darroudi - Journal of cellular physiology, 2019 - Wiley Online Library
Despite great advances in the field of vaccination, there are still needs for novel and
effective vaccines because still no effective vaccines have been produced for some …

Recent advances in peptide-based subunit nanovaccines

M Skwarczynski, I Toth - Nanomedicine, 2014 - Taylor & Francis
Vaccination is the most efficient way to protect humans against pathogens. Peptide-based
vaccines offer several advantages over classical vaccines, which utilized whole organisms …

[HTML][HTML] Navigating the immune maze: pioneering strategies for unshackling cancer immunotherapy resistance

L Yao, Q Wang, W Ma - Cancers, 2023 - mdpi.com
Simple Summary Cancer treatments have made remarkable advances with the introduction
of immunotherapy, which recruits the body's immune system to fight cancer. Despite these …

Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen

SS Saluja, DJ Hanlon, FA Sharp, E Hong… - International journal …, 2014 - Taylor & Francis
Targeting antigen to dendritic cells (DCs) is a powerful and novel strategy for vaccination.
Priming or loading DCs with antigen controls whether subsequent immunity will develop and …

PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses

W Ma, M Chen, S Kaushal, M McElroy… - International journal …, 2012 - Taylor & Francis
The peptide vaccine clinical trials encountered limited success because of difficulties
associated with stability and delivery, resulting in inefficient antigen presentation and low …

Interaction of nanoparticles with immunocompetent cells: nanosafety considerations

D Boraschi, L Costantino, P Italiani - Nanomedicine, 2012 - Taylor & Francis
Intentional delivery of high doses of nanoparticle-based drugs or diagnostic/imaging
systems sets a new scenario in safety evaluation, compared with the environmentally borne …

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination

F Benencia, L Sprague, J McGinty… - BioMed Research …, 2012 - Wiley Online Library
Many clinical trials have been carried out or are in progress to assess the therapeutic
potential of dendritic‐cell‐(DC‐) based vaccines on cancer patients, and recently the first DC …

Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery

N Marasini, AK Giddam, ZG Khalil, WM Hussein… - …, 2016 - Taylor & Francis
Aim: To develop novel polymer-based nanoscale delivery system for lipopeptide-based
vaccine against group A Streptococcus (GAS). Materials & methods: Four types of …